Clinical Trials

50 enrolled

Phase 2 Not yet recruiting

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07024706 2026-01-21

MAVRiC

80 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07342478 2026-01-16

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

306 enrolled

Chromosome 17 deletion, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07296445 2025-12-29

LATITUDE

120 enrolled

Leukemia, Leukemia, Promyelocytic, Acute

NCT07306832 2025-12-29

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

18 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT07303660 2025-12-26

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

66 enrolled

Leukemia, Myeloid, Acute

NCT07294300 2025-12-19

A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies

124 enrolled

Hematologic Neoplasms

NCT06906380 2025-12-08

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Classical hematologyOther hematologic neoplasm

49 enrolled

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT06225050 2025-12-03

HAPLO2022

Phase NA Not yet recruiting

18 enrolled

Hematologic Neoplasms

NCT07255898 2025-12-01

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Other hematologic neoplasmPlasma cell

33 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT06979076 2025-09-29

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

12 enrolled

Phase 2 Not yet recruiting

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06987058 2025-09-24

ROVER-01

10 enrolled

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Myeloid, Acute

NCT06281847 2025-09-18

RESOLVE AML001

143 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

LymphoidOther hematologic neoplasmPlasma cell

116 enrolled

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07157514 2025-09-10

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Phase 2/3 Not yet recruiting

306 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT07137637 2025-08-22

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

60 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

NCT07123662 2025-08-14

γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

8 enrolled

Leukemia

NCT07091019 2025-07-29

ASC4REAL-2

1,000 enrolled

Leukemia, Myeloid, Chronic-Phase

NCT07084584 2025-07-24

An Open-label, Dose-Escalation and Dose-Expansion Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

184 enrolled

Leukemia, Myeloid, Acute

NCT06894693 2025-03-25

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

13 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06702098 2024-11-22

iNK-r/r AML

10 enrolled

Leukemia, Myeloid, Acute

NCT06672263 2024-11-04

A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia

120 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06641024 2024-10-15

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

24 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06530810 2024-07-31

Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

100 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT06463327 2024-06-17

ACHIEVE2

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06441084 2024-06-04

A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation

15 enrolled

Leukemia, Myeloid, Acute

NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

83 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06387420 2024-04-29

A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia

180 enrolled

Phase 2 Not yet recruiting

Leukemia, Myeloid, Acute

NCT06367114 2024-04-19

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

50 enrolled

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06347458 2024-04-04

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

24 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT06333509 2024-03-27

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

Other hematologic neoplasmPlasma cell

166 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT06211751 2024-01-18

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

208 enrolled

Hematologic Neoplasms

NCT06182592 2023-12-28

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

120 enrolled

Neoplasm Metastasis, Leukemia, Myeloid, Acute

NCT05899543 2023-06-12

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

500 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05859932 2023-05-16

Assessing Medical Trial Experiences of Hairy Cell Leukemia Patients

500 enrolled

Leukemia, Hairy Cell

NCT05381181 2023-01-27

Safety and Efficacy Evaluation of Next-generation CD19-UCART

20 enrolled

Phase 4 Not yet recruiting

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05367765 2022-05-10

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

2,400 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT05055791 2021-09-24

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies